Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies

Onco · Published 2026-08-03 · DOI 10.3390/onco6030039

Free full text

Authors (2)

Federico Venturi, Emi Dika

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Venturi, F., Dika, E. (2026). Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies. Onco. https://doi.org/10.3390/onco6030039

Related articles

• Cutaneous adverse events associated with new cancer therapies · Current Opinion in Allergy and Clinical Immunology · 2026 · Cites or is cited by this article
• Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data · Clinical Pharmacology and Therapeutics · 2026 · Cites or is cited by this article
• Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review · Current Oncology Reports · 2026 · Cites or is cited by this article
• STEPP for the EGFR Inhibitor–Induced Rash—Definitely a Step in the Right Direction · Current Oncology Reports · 2010 · Cites or is cited by this article
• Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors. · Dermatology · Cites or is cited by this article
• The Male Predominance in HBV-Related Hepatocellular Carcinoma: Unraveling the Axis of Androgen Receptor, Viral Replication, and Immune Evasion via NKG2D Ligands · Onco · 2026 · Same journal
• Hub Gene Clusters Reveal Dysregulated Synaptic Neurotransmitter Signaling Pathways and Drug Repurposing Prospect in Brain Tumors · Onco · 2026 · Same journal
• Navigating Rarity: Pathological Challenges and Diagnostic Ambiguity in Rare Gliomas—A Case Series with a Focus on Personalized Treatment and Quality of Life · Onco · 2025 · Same journal
• Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment · Onco · 2025 · Same journal
• Advancing Immunotherapy in Cervical Cancer: Biological Rationale, Clinical Evidence, and Biomarker Standardization · Onco · 2026 · Same journal